• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Deals this week: Swedish Orphan Biovitrum, Vectura pharmaceutical
    November 19, 2018
    Swedish Orphan Biovitrum (Sobi) has entered an agreement to purchase the US rights for Synagis from AstraZeneca for $1.5bn.
  • AstraZeneca divests US rights to Synagis pharmatimes
    November 14, 2018
    Swedish Orphan Biovitrum AB has entered into an agreement to buy US rights to AstraZeneca’s Synagis, licensed for the prevention of serious lower respiratory tract infection caused by respiratory syncytial virus (RSV).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service